TWST — Twist Bioscience Balance Sheet
0.000.00%
- $2.16bn
- $1.93bn
- $376.57m
- 73
- 24
- 27
- 35
Annual balance sheet for Twist Bioscience, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 478 | 505 | 336 | 276 | 232 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 28.5 | 40.3 | 44.1 | 34.9 | 57 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 546 | 596 | 424 | 347 | 333 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 106 | 214 | 203 | 161 | 152 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 702 | 961 | 776 | 614 | 642 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 63.1 | 90.7 | 73.3 | 71 | 91.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 121 | 172 | 153 | 142 | 169 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 581 | 789 | 623 | 473 | 473 |
| Total Liabilities & Shareholders' Equity | 702 | 961 | 776 | 614 | 642 |
| Total Common Shares Outstanding |